| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |